JOFABYO
Live / Allowed — Published for opposition (as of 14 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99659652
- Mark type
- Word mark
- Filed
- 18 Feb 2026
- Published for opposition
- 14 Jul 2026
- Attorney of record
- Cory Poker
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, neurodegenerative diseases, neurological disorders, anxiety, addictions including addictive eating disorders, neurodegenerative disorders including Alzheimer's disease, diseases of the central nervous system, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, and allergic diseases; Pharmaceutical preparations for the treatment of hypertension, diabetes, and kidney diseases, including chronic kidney disease, diabetic kidney disease, and kidney diseases associated with glycolipid storage disorders and Fabry disease
Owner
- IDORSIA PHARMACEUTICALS LTD, Allschwil, CH
- IDORSIA PHARMACEUTICALS LTD, Allschwil, CH
Prosecution history
- 14 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jul 2026 — PUBLISHED FOR OPPOSITION
- 08 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Jun 2026 — ASSIGNED TO EXAMINER
- 18 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 18 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Feb 2026 — NEW APPLICATION ENTERED